Literature DB >> 25288857

Commentary.

Yoshimasa Mori1.   

Abstract

Entities:  

Year:  2014        PMID: 25288857      PMCID: PMC4173252     

Source DB:  PubMed          Journal:  J Neurosci Rural Pract        ISSN: 0976-3155


× No keyword cloud information.
The authors presented two rare cases of scalp malignant nodular hidradenoma (MNH).[1] Both tumors recurred in spite of total excision and radiotherapy. The preferred treatment is an early wide surgical excision of the tumor. Recently, innovation of radiation delivery technique enabled IMRT (intensity modulated radiation therapy) for complex-shaped targets.[2] VMAT (volumetric modulated arc therapy) or Rapid Arc[3] therapy and helical tomotherapy[4] give a high dose to widely spread scalp and skull tumors, sparing the underlying brain parenchyma as much as possible. IMRT as well as chemotherapy including the molecular targeting therapy is to be evaluated for adjuvant therapy after the surgical resection or for salvage therapy in case of recurrence.
  4 in total

1.  Brain-sparing holo-cranial radiotherapy: a unique application of helical tomotherapy.

Authors:  T Gupta; S Mallik; Z Master; R Phurailatpam; S Laskar
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-09-29       Impact factor: 4.126

2.  Total scalp radiation using image-guided IMRT for progressive cutaneous T cell lymphoma.

Authors:  R S Samant; G W Fox; L H Gerig; L A Montgomery; D S Allan
Journal:  Br J Radiol       Date:  2009-06       Impact factor: 3.039

3.  Total dural irradiation: RapidArc versus static-field IMRT: a case study.

Authors:  Paul J Kelly; Edward Mannarino; John Henry Lewis; Elizabeth H Baldini; Fred L Hacker
Journal:  Med Dosim       Date:  2011-08-20       Impact factor: 1.482

4.  Malignant nodular hidradenoma of scalp.

Authors:  Tanmoy Maiti; Sampath Somanna; Bhagavatula Indira Devi; Asha Unchagi; Dhaval Shukla
Journal:  J Neurosci Rural Pract       Date:  2014-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.